U.S. pares down recommended vaccines: what you need to know

Monday's announcement follows months of efforts by Kennedy to change the way vaccines are approved, reviewed, and recommended.

January 5, 2026 Check out STAT+

Sponsored By

The STAT Mini crossword is back, now with a new puzzle every weekday. Try your skills on today's puzzle!

Elaine Thompson/AP Federal health officials slash recommended childhood vaccinations under Trump's directive List of recommended shots drops from 17 to 11. New CDC guidelines follow a Trump order to align vaccine policy with peer nations. By Chelsea Cirruzzo and Helen Branswell STAT+ | What does Neuralink want — to help people with paralysis, or prepare for a war with AI? As brain implants show real promise for paralysis and ALS, Neuralink's talk of transhumanism and AI symbiosis is alarming and irritating BCI competitors. By O. Rose Broderick STAT+ | A biotech incubator in China tries to unlock innovation — alongside drugmakers worldwide The incubator, founded by PC Zhu, believes it can allow researchers to test drug development ideas faster than in other countries, and at lower cost. By Brian Yang Christine Kao/STAT STAT+ | 3 issues to watch in biopharma in 2026 Biopharma issues to watch in 2026 include new obesity pills, drug patent protections, and a government drug discount program known as 340B. By Ed Silverman and Elaine Chen STAT+ | The biotech scorecard for the first quarter: 26 stock-moving events to watch Here's a look at top trial readouts and FDA drug approval decisions for Uniqure, Vertex Pharmaceuticals, Wave Life Sciences, and more. By Adam Feuerstein STAT+ | Argenx CEO to step down in May, be succeeded by COO Tim Van Hauwermeiren, who cofounded the Belgian drugmaker, has been CEO since 2008. Replacing him is Karen Massey. By Adam Feuerstein Rufus Cox/Getty Images Opinion: Public health data should be as available as the weather forecast By localizing public health data, we can strengthen efficiency, rebuild trust, and improve outcomes, writes Deborah Birx. By Deborah L. Birx

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2026, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser